Static Chart Neurogene Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/03/2026 GMT			5-day change	1st Jan Change
22.17 ^USD	+0.18%		-5.62%	+7.62%

03-03	Neurogene announces inducement grants under Nasdaq Listing Rule 5635(c)(4)	RE
02-26	Neurogene announces FDA breakthrough therapy designation for NGN-401 gene therapy for Rett syndrome	RE

Duration

Period